GMED Globus Medical Inc Class A

Globus Medical to participate in the Canaccord Genuity 2025 Musculoskeletal Conference

Globus Medical to participate in the Canaccord Genuity 2025 Musculoskeletal Conference

Monday, March 10, 2025 at 4:30 pm Pacific Time

AUDUBON, Pa., March 05, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it is scheduled to participate in the Canaccord Genuity 2025 Musculoskeletal Conference in San Diego. Management is scheduled to present on Monday, March 10, 2025 at 4:30 pm PT.

Interested parties can access the live and archived webcast of the presentation in the “News & Events”, “Events & Webcasts” section of the Globus Medical investor relations website at .  

About Globus Medical, Inc. 

Based in Audubon, Pennsylvania, Globus Medical, Inc. is a leading global musculoskeletal technology company dedicated to solving unmet clinical needs and changing lives. We innovate with inspired urgency, provide world-class education and clinical support, and advance care throughout spine, orthopedic trauma, joint reconstruction, regenerative biomaterials and enabling technologies. Additional information can be accessed at .  

Investor contact: 

Brian Kearns 

610-930-1800 

 

Media contact: 

Moran Chavez 

 



EN
06/03/2025

Underlying

GMEDGlobus Medical Inc Class A

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Globus Medical Inc Class A

 PRESS RELEASE
Free
GMED Globus Medical ...

Globus Medical Announces Leadership Transitions and Preliminary Second...

Globus Medical Announces Leadership Transitions and Preliminary Second Quarter 2025 Sales Results AUDUBON, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced that Keith Pfeil, Executive Vice President, Chief Operating Officer and Chief Financial Officer, has been appointed President and Chief Executive Officer effective July 18, 2025. Daniel Scavilla has resigned as President and Chief Executive Officer effective July 18, 2025, in order to pursue another opportunity. Additionally, Kyle Kline, Senior Vice ...

July 21, 2025 1 EN
 PRESS RELEASE
Free
GMED Globus Medical ...

Globus Medical Schedules Second Quarter Earnings Release and Conferenc...

Globus Medical Schedules Second Quarter Earnings Release and Conference Call AUDUBON, Pa., July 17, 2025 (GLOBE NEWSWIRE) -- , Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the second quarter ended June 30, 2025 after the market close on Thursday, August 7, 2025. A copy of the release will be available on the Globus Medical website at . Following the announcement, Globus Medical will hold a teleconference to discuss its performance with the investment community at 4:30 p.m. Eastern Time. Participants may access the conference call...

July 17, 2025 1 EN
 PRESS RELEASE
Free
GMED Globus Medical ...

Globus Medical Introduces DuraPro™ with Navigation, a Next-Generation,...

Globus Medical Introduces DuraPro™ with Navigation, a Next-Generation, Oscillating System Designed to Safeguard Delicate Tissue AUDUBON, Pa., July 15, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the expanded Excelsius™ navigation capabilities of its next-generation oscillating system, DuraPro™, as the latest addition to the Power Portfolio, designed to advance procedural workflows through safety features and efficiency. “Our goal is to revolutionize the $550 million high-speed drill market with the introduction ...

July 15, 2025 1 EN
 PRESS RELEASE
Free
GMED Globus Medical ...

Globus Medical Announces $500 Million Share Repurchase Program

Globus Medical Announces $500 Million Share Repurchase Program AUDUBON, Pa., May 15, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced that its Board of Directors has authorized a share repurchase program of up to $500 million of the Company’s outstanding common stock. “We believe the recent volatility in our share price has created a meaningful disconnect between our intrinsic value and our market valuation,” said Keith Pfeil, Chief Financial Officer and Chief Operating Officer of Globus Medical. “Given our strong tr...

May 15, 2025 1 EN
 PRESS RELEASE
Free
GMED Globus Medical ...

Globus Medical Reports First Quarter 2025 Results

Globus Medical Reports First Quarter 2025 Results AUDUBON, Pa., May 08, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended March 31, 2025. Worldwide net sales were $598.1 million, a decrease of 1.4%, or a decrease of 0.8% on a constant currency basisGAAP net income for the quarter was $75.5 millionGAAP diluted earnings per share (“EPS”) was $0.54 and non-GAAP diluted EPS was $0.68 “Our first quarter results were impacted by softer Enabling Technology deal closures, tempo...

May 8, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch